| Dr Curt James Degenhart, PSYD | |
|
614 Hammond St Ste 2, Chestnut Hill, MA 02467-2161 | |
| (617) 861-9822 | |
| Not Available |
| Full Name | Dr Curt James Degenhart |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 614 Hammond St Ste 2, Chestnut Hill, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326471186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 10779 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Curt James Degenhart, PSYD 138 Harvard St, Newton, MA 02460-2204 Ph: (617) 331-0669 | Dr Curt James Degenhart, PSYD 614 Hammond St Ste 2, Chestnut Hill, MA 02467-2161 Ph: (617) 861-9822 |
News Archive
Nursing home care quality does not impact the likelihood of patients being readmitted to the hospital or dying within 30 days of discharge from hospital to nursing home, according to a new analysis of Medicare data and nursing home performance measures by Penn Medicine researchers.
Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that the company has entered an agreement with U.S. Department of Commerce's Commercial Service to become a Featured U.S. Exporter (FUSE) of bioterrorism monitoring equipment in France.
The National Heart, Lung and Blood Institute has awarded a total of $16.7 million to Irwin Bernstein, M.D., and Beverly Torok-Storb, Ph.D., both members of the Clinical Research Division at Fred Hutchinson Cancer Research Center.
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.
› Verified 2 days ago
Dr. Elizabeth Elaine Sparks, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 140 Commonwealth Ave, Chestnut Hill, MA 02467 Phone: 617-552-0698 Fax: 617-552-0398 | |
Dr. Rona Bonnie Knight, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 56 Monadnock Road, Chestnut Hill, MA 02467 Phone: 617-969-5797 | |
Dr. Diane M. Greene, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 147 Wallis Rd, Chestnut Hill, MA 02467 Phone: 617-522-5553 Fax: 508-349-2911 | |
Dr. Carol Rubin, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 58 Reservoir Avenue, Chestnut Hill, MA 02467 Phone: 617-734-8297 | |
Dr. Maggie Hogan, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 140 Commonwealth Ave, Chestnut Hill, MA 02467 Phone: 617-552-3310 | |
Dr. Fred Busch, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 246 Eliot St, Chestnut Hill, MA 02467 Phone: 617-232-5674 | |
Dr. Lynn Walsh-blair, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 140 Commonwealth Ave, Chestnut Hill, MA 02467 Phone: 617-552-3310 |